Then minister of finance Sri Mulyani Indrawati once introduced a policy to boost revenues from pharmaceutical companies via capping of advertising and marketing costs. The policy was short-lived due to political pressures. Financial statements of pharmaceutical companies in the past few years, however, point to the need of reintroduction of the policy. Why?

To subscribe please click here